GHRH and myocardial infarction: The reduction of MI size and increase in the number of mitotic cardiomyocytes provide evidence that administration of GHRH agonists enhances myocyte renewal and stimulates cardiac growth after MI, providing an effective therapeutic strategy to rescue/repair the infarcted heart.